CS221831B2 - Method of preparation of the anti-inflammation steroid mixture of the type 9-chlore-11beta,17,21-trihydroxy-16beta-methyl-1,4-pregnadine-3,20-dion17,21-dipropionate pulverised on the size of particles mlesser than 5 min and fluorchlor-hydrocarbon utilized as actuating substace - Google Patents

Method of preparation of the anti-inflammation steroid mixture of the type 9-chlore-11beta,17,21-trihydroxy-16beta-methyl-1,4-pregnadine-3,20-dion17,21-dipropionate pulverised on the size of particles mlesser than 5 min and fluorchlor-hydrocarbon utilized as actuating substace Download PDF

Info

Publication number
CS221831B2
CS221831B2 CS813676A CS367681A CS221831B2 CS 221831 B2 CS221831 B2 CS 221831B2 CS 813676 A CS813676 A CS 813676A CS 367681 A CS367681 A CS 367681A CS 221831 B2 CS221831 B2 CS 221831B2
Authority
CS
Czechoslovakia
Prior art keywords
propellant
steroid
particles
dipropionate
particle size
Prior art date
Application number
CS813676A
Other languages
Czech (cs)
English (en)
Inventor
Paavo T Tanskanen
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of CS221831B2 publication Critical patent/CS221831B2/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K3/00—Materials not provided for elsewhere
    • C09K3/30—Materials not provided for elsewhere for aerosols

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CS813676A 1980-05-19 1981-05-18 Method of preparation of the anti-inflammation steroid mixture of the type 9-chlore-11beta,17,21-trihydroxy-16beta-methyl-1,4-pregnadine-3,20-dion17,21-dipropionate pulverised on the size of particles mlesser than 5 min and fluorchlor-hydrocarbon utilized as actuating substace CS221831B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI801610A FI63672C (fi) 1980-05-19 1980-05-19 Foerfarande foer framstaellning av en blandning av beklometasondipropionat och triklorfluormetan eller diklordifluormetan

Publications (1)

Publication Number Publication Date
CS221831B2 true CS221831B2 (en) 1983-04-29

Family

ID=8513487

Family Applications (1)

Application Number Title Priority Date Filing Date
CS813676A CS221831B2 (en) 1980-05-19 1981-05-18 Method of preparation of the anti-inflammation steroid mixture of the type 9-chlore-11beta,17,21-trihydroxy-16beta-methyl-1,4-pregnadine-3,20-dion17,21-dipropionate pulverised on the size of particles mlesser than 5 min and fluorchlor-hydrocarbon utilized as actuating substace

Country Status (21)

Country Link
US (1) US4347236A (ja)
JP (1) JPS5716820A (ja)
AT (1) AT380791B (ja)
BE (1) BE888822A (ja)
CA (1) CA1162852A (ja)
CH (1) CH647408A5 (ja)
CS (1) CS221831B2 (ja)
DD (1) DD158856A5 (ja)
DE (1) DE3119745A1 (ja)
DK (1) DK218481A (ja)
ES (1) ES8203606A1 (ja)
FI (1) FI63672C (ja)
FR (1) FR2482457A1 (ja)
GB (1) GB2076422B (ja)
HU (1) HU188093B (ja)
NL (1) NL8102457A (ja)
NO (1) NO155429C (ja)
PL (1) PL127872B1 (ja)
PT (1) PT72989B (ja)
SE (1) SE437766B (ja)
SU (1) SU1184428A3 (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR890000664B1 (ko) * 1981-10-19 1989-03-22 바리 안소니 뉴우샘 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
AU601176B2 (en) * 1986-03-10 1990-09-06 Kurt Burghart Benzodiazepine aerosols
JPH01156916A (ja) * 1987-09-25 1989-06-20 Ss Pharmaceut Co Ltd 肝疾患治療剤
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
CA2421976C (en) * 1991-12-12 2004-04-20 Glaxo Group Limited Medicaments
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
AU675633B2 (en) * 1991-12-18 1997-02-13 Minnesota Mining And Manufacturing Company Suspension aerosol formulations
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
US5376359A (en) * 1992-07-07 1994-12-27 Glaxo, Inc. Method of stabilizing aerosol formulations
MX9304585A (es) * 1992-07-31 1994-03-31 Glaxo Group Ltd Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata.
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
AU2008214205B2 (en) 2007-02-11 2014-04-24 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
US9394314B2 (en) 2012-12-21 2016-07-19 Map Pharmaceuticals, Inc. 8′-hydroxy-dihydroergotamine compounds and compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE629985A (ja) * 1962-11-29
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
JPS531814A (en) * 1976-06-28 1978-01-10 Toshiba Corp Control unit of induction motor
US4225597A (en) * 1976-10-01 1980-09-30 Schering Corporation Beclomethasone dipropionate-hexane solvate and aerosols prepared therefrom
IT1121513B (it) * 1979-05-28 1986-04-02 Chiesi Farma Spa Processo per la conversione di umo steroide antiinfiammatorio in una forma suscettibile di essere somministarta come aerosol

Also Published As

Publication number Publication date
JPS5716820A (en) 1982-01-28
SU1184428A3 (ru) 1985-10-07
US4347236A (en) 1982-08-31
FR2482457A1 (fr) 1981-11-20
HU188093B (en) 1986-03-28
NL8102457A (nl) 1981-12-16
ES502286A0 (es) 1982-04-01
DD158856A5 (de) 1983-02-09
PL127872B1 (en) 1983-12-31
GB2076422A (en) 1981-12-02
CH647408A5 (de) 1985-01-31
DK218481A (da) 1981-11-20
CA1162852A (en) 1984-02-28
ES8203606A1 (es) 1982-04-01
PL231220A1 (ja) 1982-01-18
ATA179181A (de) 1985-12-15
NO811686L (no) 1981-11-20
FI63672B (fi) 1983-04-29
NO155429C (no) 1987-04-01
FI63672C (fi) 1983-08-10
PT72989B (en) 1983-07-06
AT380791B (de) 1986-07-10
SE437766B (sv) 1985-03-18
BE888822A (fr) 1981-11-16
GB2076422B (en) 1983-12-14
FR2482457B1 (ja) 1985-01-04
DE3119745A1 (de) 1982-02-11
NO155429B (no) 1986-12-22
SE8103143L (sv) 1981-11-20
FI801610A (fi) 1981-11-20
PT72989A (en) 1981-06-01

Similar Documents

Publication Publication Date Title
CS221831B2 (en) Method of preparation of the anti-inflammation steroid mixture of the type 9-chlore-11beta,17,21-trihydroxy-16beta-methyl-1,4-pregnadine-3,20-dion17,21-dipropionate pulverised on the size of particles mlesser than 5 min and fluorchlor-hydrocarbon utilized as actuating substace
US4810488A (en) Physically modified beclomethasone dipropionate suitable for use in aerosols
RU2294737C2 (ru) Медицинские аэрозольные составы
US4364923A (en) Chemical compounds
EP0536204B1 (en) The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
EP0162556B1 (en) Novels forms and formulations of nedocromil sodium
CA1075228A (en) Flunisolide to treat respiratory diseases
EP0260241A1 (en) A new system for administration of liposomes to mammals
SE442267B (sv) Forfarande for framstellning av en farmaceutisk komposition innehallande dinatriumsaltet av 1,3-bis (2-karboxikromon-5-yloxi)propan-2-ol
US4913892A (en) Preparation and use of new solvates of beclomethasone 17,21-dipropionate
US4225597A (en) Beclomethasone dipropionate-hexane solvate and aerosols prepared therefrom
US4933168A (en) Stable, crystalline flunisolide
AU645366B2 (en) Aerosol composition and a process preparing same
IE47128B1 (en) Pressurised aerosol formulation
FI67299B (fi) Foerfarande foer framstaellning av ett alkansolvat av beklometasondipropionat
CA1176171A (en) Compositions containing the disodium salt of 1,3- bis(2-carboxychromon-5-yloxy)-propan-2-ol
GB2196254A (en) Nedocromil sodium formation
HU180348B (hu) Eljárás beklometazon-észter-szolvátok előállítására
GB1562901A (en) Disodium cromoglycate
JPH0129199B2 (ja)
DD299211A7 (de) Verfahren zur herstellung einer aerosolformulierung